Companies / Rhythm Pharmaceuticals, Inc. / Activity
Activity — Rhythm Pharmaceuticals, Inc.
109 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 1, 2026 | German Christopher Paul Executive | Exercise | Restricted Stock Units | — | -2K -33.33% | 3,612 <0.01% of shares | low |
| Feb 1, 2026 | German Christopher Paul Executive | Exercise | Common Stock | — | +4K +377.14% | 4,571 <0.01% of shares | low |
| Feb 1, 2026 | Garfield Alastair Executive | Exercise | Restricted Stock Units | — | -7K -25.00% | 19,987 0.03% of shares | low |
| Feb 1, 2026 | Garfield Alastair Executive | Exercise | Common Stock | — | +7K +213.15% | 9,789 0.01% of shares | low |
| Feb 1, 2026 | Cramer Pamela J. Executive | Exercise | Restricted Stock Units | — | -5K -25.00% | 15,000 0.02% of shares | low |
| Feb 1, 2026 | Cramer Pamela J. Executive | Exercise | Restricted Stock Units | — | -3K -33.33% | 6,600 <0.01% of shares | low |
| Feb 1, 2026 | Cramer Pamela J. Executive | Exercise | Restricted Stock Units | — | -3K -50.00% | 2,650 <0.01% of shares | low |
| Feb 1, 2026 | Cramer Pamela J. Executive | Exercise | Restricted Stock Units | — | -2K -100.00% | 0 0.00% of shares | low |
| Feb 1, 2026 | Cramer Pamela J. Executive | Exercise | Common Stock | — | +13K +63.87% | 34,107 0.05% of shares | low |